Scalable production of adeno-associated virus type 2 vectors via suspension transfection

被引:40
作者
Park, Joon Young [1 ]
Lim, Byung-Pil [1 ]
Lee, Kyuhyun [1 ]
Kim, Young-Gun [1 ]
Jo, Eui-Cheol [1 ]
机构
[1] MOGAM Biotechnol Res Inst, Yongin 449913, Kyonggi, South Korea
关键词
adeno-associated virus vectors; vector production; polyethylenimine (PEI); suspension transfection; bioreactor;
D O I
10.1002/bit.20776
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Vectors derived from adeno-associated virus type 2 (AAV2) are promising gene delivery vehicles, but it is still challenging to get the large number of recombinant adeno-associated virus (rAAV) particles required for large animal and clinical studies. Current transfection technology requires adherent cultures of HEK 293 cells that can only be expanded by preparing multiple culture plates. A single large-scale suspension culture could replace these multiple culture preparations, but there is currently no effective co-transfection scheme for generating rAAV from cells in suspension culture. Here, we weaned HEK 293 cells to suspension culture using hydrogel-coated six-well culture plates and established an efficient transfection strategy suitable for these cells. Then the cultures were gradually scaled up. We used linear polyethylenimine (PEI) to mediate transfection and obtained high transfection efficiencies ranging from 54% to 99%, thereby allowing efficient generation of rAAV vectors. Up to 10(13) rAAV particles and, more importantly, up to 10(11) infectious particles were generated from a 2-L bioreactor culture. The suspension-transfection strategy of this study facilitates the homogeneous preparation of rAAV at a large scale, and holds further potential as the basis for establishing a manufacturing process in a larger bioreactor. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:416 / 430
页数:15
相关论文
共 51 条
[31]   Adeno-associated virus vectors can be efficiently produced without helper virus [J].
Matsushita, T ;
Elliger, S ;
Elliger, C ;
Podsakoff, G ;
Villarreal, L ;
Kurtzman, GJ ;
Iwaki, Y ;
Colosi, P .
GENE THERAPY, 1998, 5 (07) :938-945
[32]   Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: From shake flasks to a 20-L bioreactor [J].
Meghrous, J ;
Aucoin, MG ;
Jacob, D ;
Chahal, PS ;
Arcand, N ;
Kamen, AA .
BIOTECHNOLOGY PROGRESS, 2005, 21 (01) :154-160
[33]   Productive replication of adeno-associated virus can occur in human papillomavirus type 16 (HPV-16) episome-containing keratinocytes and is augmented by the HPV-16 E2 protein [J].
Ogston, P ;
Raj, K ;
Beard, P .
JOURNAL OF VIROLOGY, 2000, 74 (08) :3494-3504
[34]  
Ponnazhagan S, 2001, CANCER RES, V61, P6313
[35]   A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines [J].
Qiao, CP ;
Wang, B ;
Zhu, XD ;
Li, J ;
Xiao, X .
JOURNAL OF VIROLOGY, 2002, 76 (24) :13015-13027
[36]   Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity [J].
Rabinowitz, JE ;
Rolling, F ;
Li, CW ;
Conrath, H ;
Xiao, WD ;
Xiao, X ;
Samulski, RJ .
JOURNAL OF VIROLOGY, 2002, 76 (02) :791-801
[37]   Adeno-associated virus vectors and hematology [J].
Russell, DW ;
Kay, MA .
BLOOD, 1999, 94 (03) :864-+
[38]   Factors influencing recombinant adeno-associated virus production [J].
Salvetti, A ;
Orève, S ;
Chadeuf, G ;
Favre, D ;
Cherel, Y ;
Champion-Arnaud, P ;
David-Ameline, J ;
Moullier, P .
HUMAN GENE THERAPY, 1998, 9 (05) :695-706
[39]   Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype [J].
Sarkar, R ;
Tetreault, R ;
Gao, GP ;
Wang, LL ;
Bell, P ;
Chandler, R ;
Wilson, JM ;
Kazazian, HH .
BLOOD, 2004, 103 (04) :1253-1260
[40]   Transient gene expression in mammalian cells grown in serum-free suspension culture [J].
Schlaeger, EJ ;
Christensen, K .
CYTOTECHNOLOGY, 1999, 30 (1-3) :71-83